Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)

Akarca, U.Hatzis, G.Kitis, G.Shouval, D.Lai, C.Cheinquer, H.Chang, T.Zink, R.Zhu, J.Brett-Smith, H.2019-10-272019-10-2720061478-3223https://hdl.handle.net/11454/38332eninfo:eu-repo/semantics/closedAccessEntecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)Conference Object2655WOS:000239938800011Q2